Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Parham Geramifar

Showing results (51-60 of 80) with videos related to

Pageof 8
Sort By:
Contrast Media & Molecular Imaging|April 16, 2020
Radiosynthesis, Biological Evaluation, and Preclinical Study of a <sup>68</sup>Ga-Labeled Cyclic RGD Peptide as an Early Diagnostic Agent for Overexpressed <i>α</i> <sub>v</sub> <i>β</i> <sub>3</sub> Integrin Receptors in Non-Small-Cell Lung CancerNazanin Pirooznia, Khosrou Abdi, Davood Beiki, et al.
Asia Oceania Journal of Nuclear Medicine & Biology|July 28, 2020
Preclinical study of a new <sup>177</sup>Lu-labeled somatostatin receptor antagonist in HT-29 human colorectal cancer cellsHossein Behnammanesh, Mostafa Erfani, Maliheh Hajiramezanali, et al.
Nuclear Medicine Communications|June 19, 2023
Diagnostic value of [ 68 Ga]Ga-Pentixafor versus [ 18 F]FDG PET/CTs in non-small cell lung cancer: a head-to-head comparative studySeyed Ali Mirshahvalad, Reyhaneh Manafi-Farid, Babak Fallahi, et al.
Clinical Genitourinary Cancer|April 9, 2024
An Update on the Role of mpMRI and <sup>68</sup>Ga-PSMA PET Imaging in Primary and Recurrent Prostate CancerHamed Bagheri, Seyed Rabi Mahdavi, Parham Geramifar, et al.
Nuclear Medicine and Molecular Imaging|August 18, 2015
Preparation and Evaluation of (68)Ga-ECC as a PET Renal Imaging AgentAlireza Mirzaei, Amir Reza Jalilian, Ayuob Aghanejad, et al.
European Radiology|June 23, 2019
Direct attenuation correction of brain PET images using only emission data via a deep convolutional encoder-decoder (Deep-DAC)Isaac Shiri, Pardis Ghafarian, Parham Geramifar, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 15, 2021
Deep learning-based denoising of low-dose SPECT myocardial perfusion images: quantitative assessment and clinical performanceNarges Aghakhan Olia, Alireza Kamali-Asl, Sanaz Hariri Tabrizi, et al.
Medical Physics|July 3, 2020
Repeatability of radiomic features in magnetic resonance imaging of glioblastoma: Test-retest and image registration analysesIsaac Shiri, Ghasem Hajianfar, Ahmad Sohrabi, et al.
Bioorganic Chemistry|October 31, 2019
Design, preparation and biological evaluation of a <sup>177</sup>Lu-labeled somatostatin receptor antagonist for targeted therapy of neuroendocrine tumorsHossein Behnammanesh, Safura Jokar, Mostafa Erfani, et al.
Advances in Radiation Oncology|July 23, 2025
Comparative Analysis of <sup>68</sup>Ga-Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography and Multiparametric Magnetic Resonance Imaging for Gross Tumor Volume Delineation in Radiation Therapy Planning of Prostate CancerHamed Bagheri, Seied Rabi Mahdavi, Parham Geramifar, et al.
Pageof 8

Showing results (51-60 of 80) with videos related to

Sort By:
Pageof 8
Contrast Media & Molecular Imaging|April 16, 2020
Radiosynthesis, Biological Evaluation, and Preclinical Study of a <sup>68</sup>Ga-Labeled Cyclic RGD Peptide as an Early Diagnostic Agent for Overexpressed <i>α</i> <sub>v</sub> <i>β</i> <sub>3</sub> Integrin Receptors in Non-Small-Cell Lung CancerNazanin Pirooznia, Khosrou Abdi, Davood Beiki, et al.
Asia Oceania Journal of Nuclear Medicine & Biology|July 28, 2020
Preclinical study of a new <sup>177</sup>Lu-labeled somatostatin receptor antagonist in HT-29 human colorectal cancer cellsHossein Behnammanesh, Mostafa Erfani, Maliheh Hajiramezanali, et al.
Nuclear Medicine Communications|June 19, 2023
Diagnostic value of [ 68 Ga]Ga-Pentixafor versus [ 18 F]FDG PET/CTs in non-small cell lung cancer: a head-to-head comparative studySeyed Ali Mirshahvalad, Reyhaneh Manafi-Farid, Babak Fallahi, et al.
Clinical Genitourinary Cancer|April 9, 2024
An Update on the Role of mpMRI and <sup>68</sup>Ga-PSMA PET Imaging in Primary and Recurrent Prostate CancerHamed Bagheri, Seyed Rabi Mahdavi, Parham Geramifar, et al.
Nuclear Medicine and Molecular Imaging|August 18, 2015
Preparation and Evaluation of (68)Ga-ECC as a PET Renal Imaging AgentAlireza Mirzaei, Amir Reza Jalilian, Ayuob Aghanejad, et al.
European Radiology|June 23, 2019
Direct attenuation correction of brain PET images using only emission data via a deep convolutional encoder-decoder (Deep-DAC)Isaac Shiri, Pardis Ghafarian, Parham Geramifar, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 15, 2021
Deep learning-based denoising of low-dose SPECT myocardial perfusion images: quantitative assessment and clinical performanceNarges Aghakhan Olia, Alireza Kamali-Asl, Sanaz Hariri Tabrizi, et al.
Medical Physics|July 3, 2020
Repeatability of radiomic features in magnetic resonance imaging of glioblastoma: Test-retest and image registration analysesIsaac Shiri, Ghasem Hajianfar, Ahmad Sohrabi, et al.
Bioorganic Chemistry|October 31, 2019
Design, preparation and biological evaluation of a <sup>177</sup>Lu-labeled somatostatin receptor antagonist for targeted therapy of neuroendocrine tumorsHossein Behnammanesh, Safura Jokar, Mostafa Erfani, et al.
Advances in Radiation Oncology|July 23, 2025
Comparative Analysis of <sup>68</sup>Ga-Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography and Multiparametric Magnetic Resonance Imaging for Gross Tumor Volume Delineation in Radiation Therapy Planning of Prostate CancerHamed Bagheri, Seied Rabi Mahdavi, Parham Geramifar, et al.
Pageof 8